NASHUA, NH and BOSTON, MA (#T1) – April 20, 2017 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System will be presented during the American Brachytherapy Society (ABS) Annual Meeting in Boston, MA. The Xoft System and its suite of products will also be showcased at the Xoft booth (#T1) from April 21-22, 2017.

“This important data presentation represents a significant milestone for our company in continuing to expand the growing body of research highlighting the Xoft System’s clinical value to patients and clinicians alike,” said Ken Ferry, CEO of iCAD. “As more clinicians report on the safety and efficacy of the Xoft System, their insights continue to validate our commitment to this advanced technology offering tangible benefits to certain women diagnosed with early-stage breast cancer.”

At the meeting, Gary Proulx, M.D., Medical Director, Radiation Oncology at Exeter Hospital will present updated findings on his recent clinical experience treating 94 early-stage breast cancer patients with IORT using the Xoft System in a snap oral presentation entitled “Intraoperative Radiation (IORT) as Adjuvant Radiation Monotherapy for Early-Stage Breast Cancer Patients Treated with Breast Conserving Surgery.”

“Early results from our research suggest that this short course of full dose radiation in a single treatment offers a low rate of local failure and a high rate of excellent cosmesis for properly selected patients. We are happy to report that 100% of patients were very pleased with the treatment experience and treatment outcome on follow up visits,” said Dr. Proulx. “I am very encouraged by the early results of our research that indicate improved quality of life for patients eligible for IORT by greatly reducing the number of treatments patients receive when compared to EBRT.”

Details regarding the presentation by Dr. Proulx are as follows:

Session: Scientific Session: Breast Snap Orals
Date/Time: Friday, April 21, 2017
Time of Presentation: 6:25 - 6:30 pm ET
Publication/Presentation Number: BSOR9

In addition, Ajay Bhatnagar, MD, MBA, Radiation Oncologist at 21st Century Oncology, will participate in a panel discussion and several workshops during the meeting to review his recent clinical experience in treating nonmelanoma skin cancer (NMSC) with the Xoft System. Dr. Bhatnagar will participate in the following discussions during the ABS meeting:

Rad Oncology Homepage